HLA-A and neoplasm: It is noteworthy from the clinical data, i.e., elevated expression of these genes at the primary tumor, was associated with both a poor survival (e.g., Fig 9: FLNB [49] and H1F0 [50] genes) as well as an enhanced or better survival (e.g., CDC42 & HLA-A, lower portion of Table 16).